Omixon on LinkedIn!

We see amazing potential in using social media channels for spreading the word about next generation sequencing, HLA typing and bioinformatics in general. This is why we have been writing this blog, updating the Facebook and Twitter channels and now we open a new channel on LinkedIn. We hope...

 

Read more

US Supreme Court Rules on DNA Patents

A long debate comes to an end today as the US Supreme Court upends patentability of genes! The supreme court decision opens opportunities for BRCA testing by Next Generation Sequencing, but how you find those long indels? This is where we help! Here is how our method was checked...

 

Read more

Omixon and Knome partner to offer advanced HLA typing for whole genome!

We have great news today as Omixon Biocomputing and Knome has become partners to offer advanced HLA typing for whole genome and exome level data. We believe that this partnership will help us “discover safer and more efficient therapies by identifying genomic biomarkers for drug response and adverse response,”...

 

Read more

Omixon at EFI 2013, Maastricht

DAY 1 Omixon was exhibiting and EFI 2013 conference in Maastricht. As this conference was focusing on immunogenetics, everything was about HLA. So we were preparing very hard to be on our best shape during these few days. The opening ceremony was on Saturday evening.

 

Read more